Skip to main content

Table 2 Antiretroviral drugs included in SQV/r regimens.

From: The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients

  

ART-naïve

Pretreated but PI-naïve

  

n

%

n

%

2 NRTI

 

129

 

74

 

54

 

59.5

 
 

TDF/FTC

 

82

 

47

 

38

 

35

 

AZT/3TC

 

29

 

17

 

4

 

4

 

3TC/ABC

 

14

 

8

 

8

 

7

PI

 

19

 

11

 

30

 

27.5

 
 

LPV

 

19

 

11

 

20

 

18

 

ATV

 

0

   

6

 

5.5

 

FAP

 

0

   

4

 

4

PI + NRTI/NNRTI

 

5

 

3

 

8

 

7

 
 

LPV

 

2

   

5

 

4.5

 

ATV

 

2

   

3

 

2.5

 

FAP

 

1

   

0

 

2

Not specified

 

0

 

0

 

1

 

1

 

Other

 

22

 

12

 

16

 

15

 
  1. NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; TDF: tenofovir; FTC: emtricitabine; AZT: zidovudine; 3TC: lamivudine; ABC: abacavir; LPV: lopinavir; ATV: atazanavir; FAP: fosamprenavir